U.S. federal trademark · Serial No. 75193897 · Reg. No. 2176134
cell culture kits comprised of reagents for extending the effective life of foreign genes, screening novel genes, vector modification, evaluation of medical system efficacy, drug effects, toxicity testing and negative drug-drug interaction determination for scientific or medical research
research and development for new products for others in the drug development market by drug screening for pharmacokinetic, toxicity testing, generic vector, reagent efficacy testing and cancer therapy screening
system comprised of a thermostat for controlling the environment in which cultured cells are grown
clinical medical reagents administered locally, intravenously, or orally in the diet to stimulate over-expression of transient or stable genes in gene therapy applications
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.